BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 79 found
  Current Search:  taxol: 79     

HTML
100%
Tales from the Chemo Front
Benaron's daughter, Molly, was a great source of comfort to her during chemo A DOCTOR BECOMES A PATIENT By Lisa Benaron, MD In 2002 I was a 42-year-old physician and mother of a five-year-old daughter when I found a lump in my breast that...
MAMM:  Jul 24 2008 5:56AM
Matching: taxol
Find similar documents
HTML
100%
Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth
- Bristol-Myers Squibb Company (NYSE:BMY) today reported very strong sales and earnings growth for the second quarter 2008 and announced additional plans to proactively manage costs.

'We are making measurable strides against the strategy...

Pharma Live:  Jul 24 2008 1:06PM
Matching: taxol
Find similar documents
HTML
100%
Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth
Bristol-Myers Squibb Company (NYSE:BMY) today reported very strong sales and earnings growth for the second quarter 2008 and announced additional plans to proactively manage costs.

'We are making measurable strides against the strategy we...

Genetic Engineering News:  Jul 24 2008 11:58AM
Matching: taxol
Find similar documents
HTML
100%
Biocon & Abraxis Bioscience Launch Abraxane in India for treatment of Breast Cancer
Biocon Ltd, India's pioneering biotechnology Company, and Abraxis BioScience, Inc, a fully integrated biotechonology Company, today announced the launch of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin...
Equity Bulls:  Jul 22 2008 12:14AM
Matching: taxol
Find similar documents
HTML
100%
Biocon, Abraxis launch Abraxane in India to treat breast cancer
Indias biotech major Biocon and Abraxis Bioscience, a fully integrated biotechnology company from the US, have launched Abraxane (paclitaxel protein-bound particles for injectable suspension) in India for the treatment of breast cancer after...
Bio Spectrum Asia:  Jul 21 2008 5:52AM
Matching: taxol
Find similar documents
HTML
100%
::: Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
BANGALORE, India, & LOS ANGELES--(BUSINESS WIRE)--Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE ...

Biotech Intelligence:  Jul 19 2008 4:37PM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
- Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE(R) (paclitaxel protein-bound particles for injectable...

DiGiTAL50:  Jul 19 2008 7:17AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
BANGALORE, India, & LOS ANGELES--(BUSINESS WIRE)--Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII - News), a fully integrated biotechnology company, today announced the launch of...

Yahoo! Canada:  Jul 18 2008 11:51AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
BANGALORE, India, & LOS ANGELES--(BUSINESS WIRE)--Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII - News), a fully integrated biotechnology company, today announced the launch of...

Yahoo!:  Jul 18 2008 11:26AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) ...

Houston Chronicle:  Jul 18 2008 11:29AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis Bioscience Launch Abraxane in India for Treatment of Breast Cancer
Source : Biocon Limited (Business Wire India) Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE ...

United News of India:  Jul 18 2008 8:21PM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
BANGALORE, India, & LOS ANGELES--(BUSINESS WIRE)--Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE ...

Business Wire:  Jul 18 2008 11:55AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
BANGALORE, India, & LOS ANGELES--(BUSINESS WIRE)--Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ: ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE ...

Yahoo! Canada:  Jul 18 2008 11:46AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch Abraxane in India for Treatment of Breast Cancer
- Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE(R) (paclitaxel protein-bound particles for injectable...

Pharma Live:  Jul 18 2008 12:08PM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
, 7:00 AM EST News source: Business Wire Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE(R) (paclitaxel...

Genetic Engineering News:  Jul 18 2008 11:25AM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis BioScience Launch ABRAXANE in India for Treatment of Breast Cancer
Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc.

(NASDAQ:ABII), a fully integrated biotechnology company, today announced the launch of ABRAXANE(R) (paclitaxel protein-bound particles for injectable...

Forbes.com:  Jul 18 2008 11:16AM
Matching: taxol
Find similar documents
HTML
100%
Biocon to market new breast cancer drug in India
Biotechnology major Biocon Ltd will market Abraxane drug of the US-based Abraxis BioScience in India for treating breast cancer, a top company official said here Friday.

To be priced at about $400 (Rs.17,200) per 100mg vial in India, the...

Webindia123:  Jul 18 2008 5:48PM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis launch breast cancer drug in India
Biocon and Abraxis BioScience have launched Abraxane in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy.Abraxane is now available in...
Datamonitor:  Jul 18 2008 3:52PM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis Launch Breast Cancer Drug in India
Biocon and Abraxis BioScience have launched Abraxane in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy.

Abraxane is now available...

Red Orbit:  Jul 18 2008 3:27PM
Matching: taxol
Find similar documents
HTML
100%
Biocon and Abraxis launch breast cancer drug in India
Abraxane is now available in India as a single-use 100mg vial (as a lyophilized powder, to be reconstituted for intravenous administration).

In October 2007, Abraxane was approved by the Drug Controller General of India.

The approval was...

TradingMarkets:  Jul 18 2008 2:27PM
Matching: taxol
Find similar documents
HTML
100%
Cancer medicine shortage
KUWAIT: Following complaints over a shortage of Taxol, a cancer treatment medicine, at the Hussein Makki Health Center, the Ministry of Health (MoH) is importing 120 ampoules to help remedy the situation.

The Center's manager, Adel...

Kuwait Times:  Jul 17 2008 4:03PM
Matching: taxol
Find similar documents
HTML
100%
SFDA approved breast cancer drug Abraxane Paclit
Abraxis BioScience, Inc., has received approval from the China State Food and Drug Administration to market Abraxane Paclitaxel for injection (Albumin Bound) for the treatment of breast cancer after failure of standard chemotherapy for...
Healthoo.com:  Jul 17 2008 1:54PM
Matching: taxol
Find similar documents
HTML
100%
Biocon & Abraxis to introduce breast cancer drug Abraxane in India
Biocon Limited and Abraxis BioScience Inc will soon launch the breast cancer drug Abraxane in India.

Abraxane (paclitaxel protein-bound particles for injectable suspension is an albumin-bound) is indicated for the treatment of breast...

PharmaBiz:  Jul 17 2008 11:58AM
Matching: taxol
Find similar documents
HTML
100%
Abraxis gets Chinese nod for breast cancer drug Abraxane Paclitaxel for injection
Abraxis BioScience, Inc., a fully integrated biotechnology company, has received approval from the China State Food and Drug Administration to market Abraxane Paclitaxel for injection (Albumin Bound) for the treatment of breast cancer after...
PharmaBiz:  Jul 16 2008 7:02AM
Matching: taxol
Find similar documents
HTML
100%
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in China
Approval of ABRAXANE Based on Pivotal Phase III Randomized Trials in the U.S.

and ChinaCompany Developing Infrastructure and Alliances in Asia-Pacific RegionLOS ANGELES--(HSMN NewsFeed)--Abraxis BioScience, Inc.

(NASDAQ:ABII ), a fully...

Healthcare Sales & Marketing Network:  Jul 16 2008 7:07PM
Matching: taxol
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.